134 related articles for article (PubMed ID: 4029889)
1. Cell-mediated cytotoxicity of sensitized spleen cells against target liver cells--in vivo and in vitro study with a mouse model of experimental autoimmune hepatitis.
Mori T; Mori Y; Yoshida H; Ueda S; Ogawa M; Iesato K; Wakashin Y; Wakashin M; Okuda K
Hepatology; 1985; 5(5):770-7. PubMed ID: 4029889
[TBL] [Abstract][Full Text] [Related]
2. Study of cellular immunity in experimental autoimmune hepatitis in mice: transfer of spleen cells sensitized with liver proteins.
Mori Y; Mori T; Ueda S; Yoshida H; Iesato K; Wakashin Y; Wakashin M; Okuda K
Clin Exp Immunol; 1985 Sep; 61(3):577-84. PubMed ID: 3878243
[TBL] [Abstract][Full Text] [Related]
3. Adoptive transfer of experimental autoimmune hepatitis in mice--cellular interaction between donor and recipient mice.
Ogawa M; Mori Y; Mori T; Ueda S; Yoshida H; Kato I; Iesato K; Wakashin Y; Azemoto R; Wakashin M
Clin Exp Immunol; 1988 Aug; 73(2):276-82. PubMed ID: 3052945
[TBL] [Abstract][Full Text] [Related]
4. Experimental systemic amyloidosis induced by immunization with syngeneic organ extracts in mice.
Mori Y; Akikusa B; Mori T; Ueda S; Iesato K; Yoshida H; Ogawa M; Kato I; Wakashin Y; Wakashin M
J Exp Med; 1986 Jun; 163(6):1553-65. PubMed ID: 3519830
[TBL] [Abstract][Full Text] [Related]
5. Cell interaction in tumor allograft immunity. Suppressor cell in the spleen of allogeneic tumor-sensitized mice.
Argyris BF; Horowitz M
Transplantation; 1976 Aug; 22(2):112-21. PubMed ID: 968933
[TBL] [Abstract][Full Text] [Related]
6. In vitro generation of suppressor cell activity: suppression of in vitro induction if cell-mediated cytotoxicity.
Hodes RJ; Hathcock KS
J Immunol; 1976 Jan; 116(1):167-77. PubMed ID: 128570
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of prostaglandin E1 on T-cell mediated cytotoxicity against isolated mouse liver cells.
Ogawa M; Mori T; Mori Y; Ueda S; Yoshida H; Kato I; Iesato K; Wakashin Y; Wakashin M; Okuda K
Gastroenterology; 1988 Apr; 94(4):1024-30. PubMed ID: 3257931
[TBL] [Abstract][Full Text] [Related]
8. Study of cellular immunity in experimental autoimmune hepatitis in mice.
Mori Y; Mori T; Yoshida H; Ueda S; Iesato K; Wakashin Y; Wakashin M; Okuda K
Clin Exp Immunol; 1984 Jul; 57(1):85-92. PubMed ID: 6430615
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the effector cells mediating an "innocent bystander" cytotoxicity reaction induced by a syngeneic mammary adenocarcinoma in mice.
Paul RD; Padmanabhan R; Lopez DM
Cancer Res; 1984 Oct; 44(10):4480-6. PubMed ID: 6467207
[TBL] [Abstract][Full Text] [Related]
10. Synergy between subpopulations of mouse spleen cells in the in vitro generation of cell-mediated cytotoxicity: evidence for the involvement of a non-T cell.
Hodes RJ; Handwerger BS; Terry WD
J Exp Med; 1974 Dec; 140(6):1646-59. PubMed ID: 4279272
[TBL] [Abstract][Full Text] [Related]
11. Natural cytotoxicity against mouse hepatitis virus-infected cells. II. A cytotoxic effector cell with a B lymphocyte phenotype.
Welsh RM; Haspel MV; Parker DC; Holmes KV
J Immunol; 1986 Feb; 136(4):1454-60. PubMed ID: 3003199
[TBL] [Abstract][Full Text] [Related]
12. Experimental hepatitis in neonatally thymectomized mice: transfer of disease and the role of T cells.
Kamiyasu M; Watanabe Y; Miura T; Masuda K; Nakanishi T; Kajiyama G; Gershwin ME
Clin Immunol Immunopathol; 1997 Jun; 83(3):302-9. PubMed ID: 9175920
[TBL] [Abstract][Full Text] [Related]
13. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of adherent versus suspension target cells derived from adherent tissue culture lines to cell-mediated cytotoxicity in rapid 51Cr-release assays.
Dorfman NA; Civin CI; Wunderlich JR
J Immunol Methods; 1980; 32(2):127-39. PubMed ID: 7358991
[TBL] [Abstract][Full Text] [Related]
15. Capacity of different cell types to stimulate cytotoxic T lymphocyte precursor cells in the presence of interleukin 2.
Dröge W; Moyers C; Wehrmaker A; Schmidt H; Panknin S; Männel D; Falk W
J Immunol; 1984 Jun; 132(6):2749-59. PubMed ID: 6233360
[TBL] [Abstract][Full Text] [Related]
16. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
Brunda MJ; Taramelli D; Holden HT; Varesio L
J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
[TBL] [Abstract][Full Text] [Related]
17. T cell-dependent nonspecific cytotoxicity induced by culture of mouse spleen cells against natural killer-insensitive tumor cells.
Kiyohara T; Tanino T; Egawa K
Jpn J Exp Med; 1982 Aug; 52(4):201-8. PubMed ID: 7176145
[TBL] [Abstract][Full Text] [Related]
18. Specificities of killing by cytotoxic lymphocytes generated in vivo and in vitro to syngeneic SV40 transformed cells.
Gooding LR
J Immunol; 1977 Mar; 118(3):920-7. PubMed ID: 191529
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic T lymphocytes reactive against a syngeneic murine tumor and their specific suppressor T cells are both elicited by in vitro allosensitization.
Leshem B; Kedar E
J Exp Med; 1990 Apr; 171(4):1057-71. PubMed ID: 2139097
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity of cultured mouse spleen cells against natural killer-sensitive target cells. Characterization of the effector cells.
Oshimi K; Kano S; Sumiya M; Gonda N; Takaku F
Int Arch Allergy Appl Immunol; 1981; 64(4):395-409. PubMed ID: 6451584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
